EPAS1 and gastric cancer: Moreover, overexpression of HIF-2α significantly reduced the pharmacological effects of Paclitaxel, Mitomycin C, Imatinib and Sorafenib on gastric cancer BGC823 cells, and the corresponding IC50 values increased markedly (Jiuda Zhao, unpublished data).